You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

~ Buy the IBRANCE (palbociclib) Drug Profile, 2024 PDF Report in the Report Store ~

Bulk Pharmaceutical API Sources for ibrance


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ibrance

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Subscribe 5330286 ⤷  Subscribe
ABI Chem ⤷  Subscribe AC1NS8RV ⤷  Subscribe
ISpharm ⤷  Subscribe S14-2748 ⤷  Subscribe
ChemMol ⤷  Subscribe 81407683 ⤷  Subscribe
ChemMol ⤷  Subscribe 49410294 ⤷  Subscribe
Amadis Chemical ⤷  Subscribe A8153 ⤷  Subscribe
Exclusive Chemistry Ltd ⤷  Subscribe PD-0332991 ⤷  Subscribe
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.